Previous 10 | Next 10 |
Gainers : Tower International (NYSE: TOWR ) +69% . Camber Energy (NYSEMKT: CEI ) +50% . HOOKIPA Pharma (NASDAQ: HOOK ) +28% . Milacron Holdings (NYSE: MCRN ) +25% . VivoPower International PLC (NASDAQ: VVPR ) +21% . ProQR Therapeutics N.V. (NASDAQ: PRQR ) +21% . Oasmi...
EMCORE (NASDAQ: EMKR ) -18% on preliminary Q3 weakness. More news on: EMCORE Corporation, Illumina, Inc., SenesTech, Inc., Stocks on the move, Read more ...
Salt Lake City, UT, July 11, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. Launches North American Mosquito Diagnostic Product Salt Lake City, Utah – Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development...
New York City, July 08, 2019 (GLOBE NEWSWIRE) -- Respected ‘Silicon Review’ lists Co-Diagnostics in 50 Fastest Growing Companies of 2019 New York City, New York – The Silicon Review’s 50 Fastest Growing Companies of the Year for 2019 features Co-Diagnostic...
Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Dr. Eugene Durenard and Mr. Ted Murphy have joined the Board of Directors of Co-Diagnostics, and will serve on the Bo...
New York City, June 26, 2019 (GLOBE NEWSWIRE) -- MedTech Outlook Names Co-Diagnostics Inc as Top 10 In-Vitro Diagnostic Provider for 2019 New York City, New York – MedTech Outlook’s 2019 Top 10 In-Vitro Diagnostics providers have been announced, including Co-Diagnostics...
Co-Diagnostics (NASDAQ: CODX ) has launched its Logix Smart ZDC multiplex test at the 64 th Annual 2019 Caribbean Public Health Agency ((CARPHA)) Health Research Conference. More news on: Co-Diagnostics, Inc., Healthcare stocks news, Read more ...
Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the launch of their Logix Smart™ ZDC multiplex test at the 64 th Annual 2019 Caribbean Public Health Agency (CARPH...
New York, May 29, 2019 (GLOBE NEWSWIRE) -- CODX Reports Initial Domestic Sales Following Release of Q1 Numbers New York City, New York – Molecular diagnostics company Co-Diagnostics (Nasdaq: CODX) reported initial sales in the US from its vector control program last week, an ...
The FDA approves Seattle, WA-based InBios International 's ZIKV Direct 2.0 IgM Capture ELISA, the first ZIKA diagnostic test commercially available in the U.S. More news on: Chembio Diagnostics, Inc., Co-Diagnostics, Inc., Roche Holding AG, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results PR Newswire SALT LAKE CITY , May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the de...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...